AAN 2024: AbbVie and NeuroDerm highlight benefits of levodopa infusions in hope of US launch
At the American Academy of Neurology (AAN) 2024 Annual Meeting, further data on AbbVie’s Produodopa/Vyalev and NeuroDerm’s ND0612 (levodopa/carbidopa) were showcased for the treatment of Parkinson’s disease (PD) in anticipation of their US …